Thalys(SH:603716) Zheng Xing Xing Ye Ri Bao·2025-10-15 08:37Market Overview - The pharmaceutical commercial sector increased by 1.0% on October 15, with Saili Medical leading the gains [1] - The Shanghai Composite Index closed at 3912.21, up 1.22%, while the Shenzhen Component Index closed at 13118.75, up 1.73% [1] Stock Performance - Saili Medical (603716) closed at 26.86, with a rise of 7.31% and a trading volume of 384,800 shares, amounting to a transaction value of 1.02 billion [1] - Baiyang Pharmaceutical (301015) rose by 4.16% to close at 27.28, with a trading volume of 49,900 shares and a transaction value of 134 million [1] - Huaren Health (301408) increased by 2.70% to close at 12.94, with a trading volume of 57,600 shares and a transaction value of 7.41 million [1] - Other notable stocks include Yiyang Pharmaceutical (2.28% increase) and Yaoyigou (1.87% increase) [1] Capital Flow - The pharmaceutical commercial sector saw a net inflow of 156 million from institutional investors, while retail investors experienced a net outflow of 1.04 billion [2] - The main stocks with significant net inflows include Saili Medical (71.52 million) and Shanghai Pharmaceutical (49.55 million) [3] - Retail investors showed a notable outflow from Shanghai Pharmaceutical, with a net outflow of 63.13 million [3]